{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:49:28Z","timestamp":1787068168901,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbr.2019.02.034","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T21:24:23Z","timestamp":1550784263000},"page":"296-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment"],"prefix":"10.1016","volume":"364","author":[{"given":"Mohaddeseh","family":"Ebrahimi-Ghiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1981-3592","authenticated-orcid":false,"given":"Mohammad","family":"Nasehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.02.034_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2298\/MPNS1606171K","article-title":"Critical review of available treatment options for treatment refractory depression and anxiety - clinical and ethical dilemmas","volume":"69","author":"Kolar","year":"2016","journal-title":"Med. Pregl."},{"key":"10.1016\/j.bbr.2019.02.034_bib0010","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.5694\/mja12.10628","article-title":"Depression and anxiety","volume":"199","author":"Tiller","year":"2013","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bbr.2019.02.034_bib0015","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/npp.2010.80","article-title":"Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus","volume":"35","author":"Bambico","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.02.034_bib0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.034_bib0025","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/npp.2014.132","article-title":"Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing","volume":"39","author":"Korem","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.02.034_bib0030","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2019.02.034_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2014.11.056","article-title":"The modulatory action of harmane on serotonergic neurotransmission in rat brain","volume":"1597","author":"Abu Ghazaleh","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.02.034_bib0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/092986707779940998","article-title":"Beta-carboline alkaloids: biochemical and pharmacological functions","volume":"14","author":"Cao","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbr.2019.02.034_bib0045","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/jm00100a004","article-title":"Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA\/GOLPE approach","volume":"35","author":"Allen","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbr.2019.02.034_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(02)01452-8","article-title":"The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets","volume":"441","author":"Rommelspacher","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bmc.2010.11.041","article-title":"Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors","volume":"19","author":"Reniers","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbr.2019.02.034_bib0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bcp.2009.05.011","article-title":"Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model","volume":"78","author":"Wu","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.euroneuro.2005.08.005","article-title":"Antidepressant-like effect of harmane and other \u03b2-carbolines in the mouse forced swim test","volume":"16","author":"Farzin","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.physbeh.2016.06.013","article-title":"Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor","volume":"164","author":"Abbassian","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2019.02.034_bib0075","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1111\/bph.13581","article-title":"Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat","volume":"173","author":"Abbassian","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0158950","article-title":"Putative epigenetic involvement of the endocannabinoid system in anxiety- and depression-related behaviors caused by nicotine as a stressor","volume":"11","author":"Hayase","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.02.034_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2012.08.074","article-title":"The effects of nicotine on nitric oxide induced anxiogenic-like behaviors in the dorsal hippocampus","volume":"528","author":"Piri","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.02.034_bib0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopha.2018.10.033","article-title":"Co-administration of the low dose of orexin and nitrergic antagonists induces an antidepressant-like effect in mice","volume":"109","author":"Alijanpour","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbr.2019.02.034_bib0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2147\/NDT.S167538","article-title":"Addictive potential of novel treatments for refractory depression and anxiety","volume":"14","author":"Kolar","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2019.02.034_bib0100","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA B receptors in the balance of gabaergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.02.034_bib0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0110","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.npp.1301330","article-title":"Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats","volume":"32","author":"Rubino","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.02.034_bib0115","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuropharm.2006.10.013","article-title":"Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray","volume":"52","author":"Moreira","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.02.034_bib0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejphar.2004.06.069","article-title":"Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress","volume":"499","author":"Hill","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00213-006-0676-9","article-title":"Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats","volume":"191","author":"Schramm-Sapyta","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.02.034_bib0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0091-3057(02)01041-9","article-title":"Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats","volume":"74","author":"Marin","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2019.02.034_bib0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/phrs.2000.0806","article-title":"Current perspectives on the development of non-biogenic amine-based antidepressants","volume":"43","author":"Skolnick","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2019.02.034_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2019.02.034_bib0145","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archgenpsychiatry.2009.156","article-title":"Brain monoamine oxidase a binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2019.02.034_bib0150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","article-title":"Inhibition of monoamine oxidase activity by cannabinoids","volume":"381","author":"Fisar","year":"2010","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0155","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14728222.12.11.1347","article-title":"The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets","volume":"12","author":"Bambico","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbr.2019.02.034_bib0160","doi-asserted-by":"crossref","DOI":"10.5607\/en.2015.24.2.156","article-title":"Chronic antidepressant treatment in Normal mice induces anxiety and impairs stress-coping ability","volume":"24","author":"Baek","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1100\/tsw.2007.48","article-title":"From the behavioral pharmacology of beta-carbolines to seizures, anxiety, and memory","volume":"7","author":"Venault","year":"2007","journal-title":"Sci. World J."},{"key":"10.1016\/j.bbr.2019.02.034_bib0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.physbeh.2018.06.007","article-title":"Effects of harmane during treadmill exercise on spatial memory of restraint-stressed mice","volume":"194","author":"Nasehi","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2019.02.034_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.11.004","article-title":"Harmaline-induced amnesia: possible role of the amygdala dopaminergic system","volume":"312","author":"Nasehi","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2019.02.034_bib0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1304.024","article-title":"Harmane induces anxiolysis and antidepressant-like effects in rats","volume":"1009","author":"Aricioglu","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbr.2019.02.034_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ntt.2014.10.005","article-title":"Effects of adolescent treatment with nicotine, harmane, or norharmane in male sprague-Dawley rats","volume":"47","author":"Goodwin","year":"2015","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.bbr.2019.02.034_bib0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/1516-4446-2015-1701","article-title":"Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies","volume":"38","author":"dos Santos","year":"2016","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.bbr.2019.02.034_bib0195","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.lfs.2006.07.004","article-title":"Effects of \u03b2-carboline alkaloids on the object recognition task in mice","volume":"79","author":"Moura","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2019.02.034_bib0200","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(92)90661-R","article-title":"Mechanisms of of action action of of ibogaine ibogaine and harmaline mechanisms harmaline congeners based on radioligand binding binding studies radioligand","volume":"571","author":"Deecher","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.02.034_bib0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0091-3057(81)90133-7","article-title":"On the neuropharmacology of harmane and other beta-carbolines","volume":"14","author":"Muller","year":"1981","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818316735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818316735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T21:26:53Z","timestamp":1574026013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818316735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":41,"alternative-id":["S0166432818316735"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.02.034","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}